Home  »  Industry   »  Who are the Institutional Holders in Nuvation Bio ...

Who are the Institutional Holders in Nuvation Bio Inc. (NUVB)?

39 institutions hold shares in Nuvation Bio Inc. (NUVB), with 60.26M shares held by insiders accounting for 27.69% while institutional investors hold 33.99% of the company’s shares. The shares outstanding are 412.96M, and float is at 13.95M with Short Float at 9.51%. Institutions hold 24.58% of the Float.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Nuvation Bio Inc. (NYSE: NUVB) is -7.26% lower on its value in year-to-date trading and has touched a low of $8.56 and a high of $15.07 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NUVB stock was last observed hovering at around $10.20 in the last trading session, with the day’s gains setting it 0.65% off its average median price target of $18.50 for the next 12 months. It is also 45.75% off the consensus price target high of $20.00 offered by 5 analysts, but current levels are 32.19% higher than the price target low of $16.00 for the same period.

Currently trading at $10.85, the stock is -12.28% and -2.94% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 6.37% at the moment leaves the stock 0.59% off its SMA200. NUVB registered a loss of -2.30% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $11.56 and a 200-day simple moving average (SMA200) of $10.81.

The stock witnessed a 3.33% gain in the last 1 month and extending the period to 3 months gives it a -7.26%, and is 5.54% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.78% over the week and 7.45% over the month.

Distance from 52-week low is 26.75% and -28.03% from its 52-week high.

Nuvation Bio Inc. (NUVB) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Nuvation Bio Inc. (NUVB) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 1.40, where 0 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Nuvation Bio Inc. is expected to release its quarterly report on 09/01/2021 and quarterly earnings per share for the current quarter are estimated at -$0.05.

Nuvation Bio Inc. (NUVB) Insider Activity

A total of 3 insider transactions have happened at Nuvation Bio Inc. (NUVB) in the last six months, with sales accounting for 0 and purchases happening 3 times.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

7 GROWTH STOCKS FOR 2021

Download Free eBook For

100% free. stop anytime no spam